Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

RARE PHOTOS: Looking into seattle genetics s return on capital employed - The Real Truth

According to data from Benzinga Pro, during Q4, Seattle Genetics's (NASDAQ:SGEN) reported sales totaled $429.85 million. Despite a 40.57% increase in earnings, the company posted a loss of $174.63 million. In Q3, Seattle Genetics brought in $424.06 million in sales but lost $293.85 million in earnings.

Why Is ROCE Significant?

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.